We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Omega-3 Fatty Acid Derivative Slows Tumor Growth by Blocking Formation of New Blood Vessels

By LabMedica International staff writers
Posted on 18 Apr 2013
A metabolite derived from an omega-3 fatty acid slows tumor growth by blocking the development of new blood vessels (angiogenesis).

Investigators at the University of California, Davis (USA) worked with cancer cell cultures and mouse cancer models to examine the effects of omega-3 and omega-6 fatty acids on tumor growth.

They reported in the April 3, 2013, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that epoxy docosapentaenoic acid (EDP), a compound produced by the human body from the fish oil omega-3 fatty acid docosahexaenoic acid (DHA), inhibited primary tumor growth and metastasis by up to nearly 70%. More...
The blocking of tumor growth was shown in a mouse cancer model to be due to EDP-mediated inhibition of vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2)-induced angiogenesis. In cancer cell cultures, EDP also suppressed the endothelial cell migration needed for new blood vessels.

In contrast, epoxyeicosatrienoic acids (EETs), metabolites of the omega-6 fatty acid arachidonic acid (ARA), slightly increased angiogenesis and tumor progression in mice.

“EDP works by a different mechanism than many current anticancer drugs that block angiogenesis,” said first author Dr. Guodong Zhang, a postdoctoral cancer researcher at the University of California, Davis. “Our investigation opens up a new understanding of the pathways by which omega-3 fatty acids exert their biologic effects. As far as we know, EDPs are the first signaling lipids that have been discovered to have such potent anticancer effects. Researchers may be able to use EDPs as structural targets to develop stable analogs as anticancer agents.”

Related Links:
University of California, Davis



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
POC Immunoassay Analyzer
Procise DX
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.